Sorrento Therapeutics IncOver The Counter Market:SRNE
- LAST PRICE0.0025
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0005 / 0.0025
- Day Range
- 52 Week Range
- Volume241,645
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SRNE |
|---|---|---|
| 09:32 ET | 6096 | 0.0025 |
| 09:33 ET | 1150 | 0.0025 |
| 09:46 ET | 201 | 0.0025 |
| 09:57 ET | 17400 | 0.0025 |
| 10:02 ET | 51158 | 0.0017 |
| 10:06 ET | 400 | 0.0027 |
| 10:13 ET | 1500 | 0.0027 |
| 10:26 ET | 1000 | 0.0027 |
| 10:27 ET | 100 | 0.0027 |
| 10:40 ET | 960 | 0.0017 |
| 10:42 ET | 24763 | 0.0027 |
| 10:47 ET | 6000 | 0.0018 |
| 10:49 ET | 100 | 0.0018 |
| 10:51 ET | 1000 | 0.0028 |
| 11:05 ET | 7000 | 0.0018 |
| 11:14 ET | 1900 | 0.0019 |
| 11:20 ET | 9350 | 0.0019 |
| 11:21 ET | 750 | 0.0025 |
| 11:48 ET | 200 | 0.0019 |
| 11:54 ET | 801 | 0.0025 |
| 12:10 ET | 139 | 0.0024 |
| 12:14 ET | 1500 | 0.0014 |
| 12:19 ET | 100 | 0.0024 |
| 12:24 ET | 7100 | 0.0025 |
| 12:28 ET | 150 | 0.0025 |
| 12:37 ET | 500 | 0.0025 |
| 12:50 ET | 1700 | 0.0025 |
| 12:55 ET | 345 | 0.0025 |
| 01:33 ET | 1000 | 0.0026 |
| 01:36 ET | 3000 | 0.0026 |
| 01:38 ET | 1000 | 0.0026 |
| 01:47 ET | 2850 | 0.0026 |
| 01:54 ET | 200 | 0.0025 |
| 01:56 ET | 100 | 0.0026 |
| 02:02 ET | 5000 | 0.0025 |
| 02:12 ET | 300 | 0.0026 |
| 02:23 ET | 145 | 0.0025 |
| 02:27 ET | 2000 | 0.0025 |
| 02:32 ET | 2000 | 0.0025 |
| 02:57 ET | 2000 | 0.0025 |
| 03:12 ET | 247 | 0.0025 |
| 03:14 ET | 6288 | 0.0025 |
| 03:28 ET | 60000 | 0.0025 |
| 03:30 ET | 5535 | 0.0025 |
| 03:50 ET | 5577 | 0.0025 |
| 04:00 ET | 178 | 0.0025 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sorrento Therapeutics Inc | 1.4M | 0.0x | --- |
MEI Pharma Inc | 18.5M | -0.4x | --- |
Molecular Templates Inc | 2.2M | -0.1x | --- |
Centogene NV | 3.0M | -0.1x | --- |
Neptune Wellness Solutions Inc | 107.9K | 0.0x | --- |
Bioqual Inc | 60.4M | 126.2x | -25.28% |
Company Information
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing a portfolio of next-generation treatments for cancer, infectious disease and pain. It also developing Resiniferatoxin (RTX), a naturally occurring non-opioid ultra-potent transient receptor potential vanilloid-1 agonist.The Company’s proprietary fully human G-MAB antibody library and ACEA small molecule library are the pipeline of new solutions for cancer. Its diagnostics platforms include the COVIMARK lateral flow antigen test and the VIREX platform.
Contact Information
- Headquarters
- 4955 Directors PlaceSAN DIEGO, CA, United States 92121
- Phone
- 858-203-4100
- Fax
- 858-203-4028
Executives
- Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
- Henry Ji
- Lead Independent Director
- Dorman Followwill
- Director
- Kim Janda
- Director
- Jaisim Shah
- Independent Director
- David Lemus
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4M |
|---|---|
Revenue (TTM) | $64.3M |
Shares Outstanding | 551.3M |
Sorrento Therapeutics Inc does not pay a dividend. | |
Beta | 1.69 |
EPS | $-1.09 |
Book Value | $-0.04 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -734.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
